0000899243-21-000710.txt : 20210106
0000899243-21-000710.hdr.sgml : 20210106
20210106164401
ACCESSION NUMBER: 0000899243-21-000710
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL FREDERICK W
CENTRAL INDEX KEY: 0001129890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 21511223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-04
0
0001645460
Cue Biopharma, Inc.
CUE
0001129890
DRISCOLL FREDERICK W
C/O CUE BIOPHARMA, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
12.36
2021-01-04
4
A
0
10000
0.00
A
2031-01-03
Common Stock
10000
10000
D
Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date.
/s/ Frederick Driscoll by Colin Sandercock, attorney-in-fact
2021-01-06